Recombinant FSH for ovulation induction in women with polycystic ovary syndrome: a comparison with urinary gonadotrophins and a comparison of different dose regimens

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Published:

24 August 2015

Authors:

Nahuis M, Bayram N, Van der Veen F, van Wely M

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Nahuis M, Bayram N, Van der Veen F, van Wely M. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD002121. DOI: 10.1002/14651858.CD002121.pub2